Report Materials
11-E-03-015.01 to CMS - Closed Unimplemented
Closed on
07/20/2023
CMS should work with Congress to require manufacturers of first generics to submit monthly ASP data during the period of initial generic availability.
View in Recommendation Tracker
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.